liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Practice patterns in diagnostics, staging, and management strategies of gallbladder cancer among Nordic tertiary centers
Helsinki Univ Hosp, Finland; Univ Helsinki, Finland.
Univ Hosp Oslo Rikshosp, Norway; Univ Tromso, Norway.
Stavanger Univ Hosp, Norway; Univ Bergen, Norway.
Karolinska Univ Hosp, Sweden.
Show others and affiliations
2023 (English)In: Scandinavian Journal of Surgery, ISSN 1457-4969, E-ISSN 1799-7267, Vol. 112, no 3, p. 147-156Article in journal (Refereed) Published
Abstract [en]

Background and objective: Gallbladder cancer (GBC) is a rare malignancy in the Nordic countries and no common Nordic treatment guidelines exist. This study aimed to characterize the current diagnostic and treatment strategies in the Nordic countries and disclose differences in these strategies. Methods: This was a survey study with a cross-sectional questionnaire of all 19 university hospitals providing curative-intent surgery for GBC in Sweden, Norway, Denmark, and Finland. Results: In all Nordic countries except Sweden, neoadjuvant/downstaging chemotherapy was used in GBC patients. In T1b and T2, majority of the centers (15-18/19) performed extended cholecystectomy. In T3, majority of the centers (13/19) performed cholecystectomy with resection of segments 4b and 5. In T4, majority of the centers (12-14/19) chose palliative/oncological care. The centers in Sweden extended lymphadenectomy beyond the hepatoduodenal ligament, whereas all other Nordic centers usually limited lymphadenectomy to the hepatoduodenal ligament. All Nordic centers except those in Norway used adjuvant chemotherapy routinely for GBC. There were no major differences between the Nordic centers in diagnostics and follow-up. Conclusions: The surgical and oncological treatment strategies of GBC vary considerably between the Nordic centers and countries.

Place, publisher, year, edition, pages
SAGE PUBLICATIONS LTD , 2023. Vol. 112, no 3, p. 147-156
Keywords [en]
Survey; biliary tract; neoplasm; MDT; resectability
National Category
Surgery
Identifiers
URN: urn:nbn:se:liu:diva-197592DOI: 10.1177/14574969231181228ISI: 001018537600001PubMedID: 37377127OAI: oai:DiVA.org:liu-197592DiVA, id: diva2:1796090
Note

Funding Agencies|Helsinki University Research Grants

Available from: 2023-09-11 Created: 2023-09-11 Last updated: 2024-04-02Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Sandström, Per A

Search in DiVA

By author/editor
Sandström, Per A
By organisation
Division of Surgery, Orthopedics and OncologyFaculty of Medicine and Health SciencesDepartment of Surgery in Linköping
In the same journal
Scandinavian Journal of Surgery
Surgery

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 56 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf